期刊文献+

De novo non-alcoholic fatty liver disease after pancreatectomy:A systematic review

下载PDF
导出
摘要 BACKGROUND As operative techniques and mortality rates of pancreatectomy have improved,there has been a shift in focus to maintaining and improving the nutritional status of these patients as we continue to learn more about post-operative complications.Although pancreatic endocrine and exocrine insufficiencies are known complications of pancreatectomy,increased longevity of these patients has also led to a higher incidence of de novo fatty liver disease which differs from traditional fatty liver disease given the lack of metabolic syndrome.AIM To identify and summarize patterns and risk factors of post-pancreatectomy de novo fatty liver disease to guide future management.METHODS We performed a database search on PubMed selecting papers published between 2001 and 2022 in the English language.PubMed was last accessed 1 June 2022.RESULTS Various factors influence the development of de novo fatty liver including indication for surgery(benign vs malignant),type of pancreatectomy,amount of pancreas remnant,and peri-operative nutritional status.With an incidence rate up to 75%,de novo non-alcoholic fatty liver disease(NAFLD)can develop within 12 mo after pancreatectomy and various risk factors have been established including pancreatic resection line and remnant pancreas volume,peri-operative malnutrition and weight loss,pancreatic exocrine insufficiency(EPI),malignancy as the indication for surgery,and postmenopausal status.CONCLUSION Since majority of risk factors leads to EPI and malnutrition,peri-operative focus on nutrition and enzymes replacement is key in preventing and treating de novo NAFLD after pancreatectomy.
出处 《World Journal of Clinical Cases》 SCIE 2022年第35期12946-12958,共13页 世界临床病例杂志
  • 相关文献

参考文献3

二级参考文献36

  • 1Juergen Siebler,Peter R Galle.Treatment of nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2006,12(14):2161-2167. 被引量:16
  • 2Angulo P.Nonalcoholic fatty liver diseaseNew England Journal of Homeopathy,2002.
  • 3Ferrero E;Jiao D;Tsuberi BZ.Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide,1993.
  • 4Sanyal AJ,Campbell-sargent C,Mirshahi F,et al.Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology . 2001
  • 5Su GL.Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. American Journal of Physiology Gastrointestinal and Liver Physiology . 2002
  • 6Hiroyuki Kato,Shuji Isaji,Yoshinori Azumi,Masashi Kishiwada,Takashi Hamada,Shugo Mizuno,Masanobu Usui,Hiroyuki Sakurai,Masami Tabata.Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system[J]. Journal of Hepato - Biliary - Pancreatic Sciences . 2010 (3)
  • 7Jeffrey R. Lewis,Smruti R. Mohanty.Nonalcoholic Fatty Liver Disease: A Review and Update[J]. Digestive Diseases and Sciences . 2010 (3)
  • 8Yuan Gao,Lin-Xuan Song,Miao-Na Jiang,Guang-Yan Ge,Yu-Jie Jia.Effects of Traditional Chinese Medicine on Endotoxin and Its Receptors in Rats with Non-Alcoholic Steatohepatitis[J]. Inflammation . 2008 (2)
  • 9Kremer M,Thomas E,Milton RJ,Perry AW,van Rooijen N,Wheeler MD,Zacks S,Fried M,Rippe RA,Hines IN.Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. Hepatology . 2010
  • 10Haziot A,Ferrero E,Lin XY,Stewart CL,Goyert SM.CD14-deficient mice are exquisitely insensitive to the effects of LPS. Progress in Clinical and Biological Research . 1995

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部